Ca2+/calmodulin-dependent protein kinase II inhibition by heparin in mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Xiao, Weiqun ^a   Liu, Ying ^a   Templeton, Douglas M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

c fos; Ca2+ ionophore; Calmodulin kinase II; Phosphorylation; Phosphothreonine

Indexed keywords

HEPARIN; IONOMYCIN; MESSENGER RNA; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSFECTION; MESANGIUM CELL; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT;

EID: 11144311101     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00145.2004     Document Type: Article

References (43)

1. 2+/calmodulin kinase types II and IV regulate c-fos transcription in the AtT20 corticotroph cell line. Mol Cell Endocrinol 120: 1-8, 1996.
2. Brickey DA, Bann JG, Fong YL, Brennan RG, and Soderling TR. Mutational analysis of the autoinhibitory domain of calmodulin kinase II. J Biol Chem 269: 29047-29054, 1994.
3. Carl M, Akagi Y, Weidner S, Isaka Y, Imai E, and Rupprecht HD. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis. Kidney Int 63: 1302-1312, 2003.
4. Castellot JJ Jr and Karnovsky MJ. Heparin and the regulation of growth of the vascular wall. In: Vascular Smooth Muscle in Culture, edited by Campbell JH and Campbells GR. Boca Raton, FL: CRC, 1987, p. 93-115.
5. Chock SP and Huang CY. An optimized continuous assay for cAMP phosphodiesterase and calmodulin. Anal Biochem 138: 34-43, 1984.
6. Clowes AW and Clowes MM. Inhibition of smooth muscle cell proliferation by heparin molecules. Transplant Proc 21: 3700-3701, 1989.
7. Daum G, Hedin U, Wang YX, Wang T, and Clowes AW. Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells. Circ Res 81: 17-23, 1997.
8. 2+ oscillations. Science 279: 227-230, 1998.
9. Duff JL, Monia BP, and Berk BC. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J Biol Chem 270: 7161-7166, 1995.
10. Flik G, Van Rijs JH, and Wendelaar Bonga SE. Evidence for the presence of calmodulin in fish mucus. Eur J Biochem 138: 651-654, 1984.
11. 2+/calmodulin-dependent protein kinase and mutational analysis of its autoregulation. Neuron 3: 59-70, 1989.
12. 2+/calmodulin-dependent protein kinase by site-directed mutagenesis. J Biol Chem 267: 17216-17224, 1992.
13. 2+/CaM-dependent kinases: from activation to function. Annu Rev Pharmacol Toxicol 41: 471-505, 2001.
14. 2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71: 473-510, 2002.
15. Johnson RJ. The glomerular response to injury: progression or resolution? Kidney Int 45: 1769-1782, 1994.
16. Kohno M, Yokokawa K, Yasunari K, Minami M, Kano H, Mandal AK, and Yoshikawa J. Heparin inhibits human coronary artery smooth muscle cell migration. Metabolism 47: 1065-1069, 1998.
17. Koyama N, Kinsella MG, Wight TN, Hedin U, and Clowes AW. Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells. Circ Res 83: 305-313, 1998.
18. Lai K, Wang H, Lee WS, Jain MK, Lee ME, and Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest 98: 1560-1567, 1996.
19. Lorca T, Cruzaleugi FH, Fesquet D, Cavadore JC, Mery J, Means A, and Doree M. Calmodulin-dependent protein kinase II mediates inactivation of the MPF and CSF upon fertilization of Xenopus eggs. Nature 366: 270-273, 1993.
20. 2+/calmodulin- dependent kinase II activation and c-fos induction in mesangial cells. Biochem J 330: 651-657, 1998.
21. Miralem T, Wang A, Whiteside CI, and Templeton DM. Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells. J Biol Chem 271: 17100-17106, 1996.
22. Mishra-Gorur K and Castellot JJ Jr. Heparin rapidly and selectively regulates protein tyrosine phosphorylation in vascular smooth muscle cells. J Cell Physiol 178: 205-215, 1999.
23. 2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells. Am J Pathol 161: 1893-1901, 2002.
24. Misra RP, Bonni A, Miranti CK, Rivera VM, Sheng M, and Greenberg ME. L-type voltage-sensitive calcium channel activation stimulates gene expression by a serum response factor-dependent pathway. J Biol Chem 269: 25483-25493, 1994.
25. 1 arrest in NIH 3T3 cells. Exp Cell Res 240: 218-227, 1998.
26. Nakanishi S, Yamada K, Iwahashi K, Kuroda K, and Kase H. KT5926, a potent and selective inhibitor of myosin light chain kinase. Mol Pharmacol 37: 482-488, 1990.
27. Penney CL. A simple microassay for inorganic phosphate. Anal Biochem 75: 201-210, 1976.
28. Pukac L, Huangpu J, and Karnovsky MJ. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp Cell Res 242: 548-560, 1998.
29. Pukac LA, Carter JE, Ottlinger ME, and Karnovsky MJ. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. J Cell Physiol 172: 69-78, 1997.
30. Pukac LA, Ottlinger ME, and Karnovsky MJ. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem 267: 3707-3711, 1992.
31. Rosen LB, Ginty DD, and Greenberg ME. Calcium regulation of gene expression. In: Advances in Second Messenger and Phosphoprotein Research, edited by Meanss AR. New York: Raven, 1995, vol. 30, p. 225-253.
32. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 57: 791-804, 1995.
33. 2+ signals. Kidney Int 58: 1876-1884, 2000.
34. Schwartz SM, deBlois D, and O'Brien ERM. The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995.
35. 2+-calmodulin-dependent protein kinase cascade. Trends Biochem Sci 24: 232-236, 1999.
36. 1 cell cycle arrest and apoptosis are induced in NIH 3T3 cells by KN-93, an inhibitor of CaMK-II. Cell Growth Differ 6: 1063-1070, 1995.
37. Wang A, Fan MY, and Templeton DM. Growth modulation and proteoglycan turnover in cultured mesangial cells. J Cell Physiol 159: 295-310, 1994.
38. Wang A and Templeton DM. Inhibition of mitogenesis and c-fos expression in mesangial cells by heparin and heparan sulfates. Kidney Int 69: 437-448, 1996.
39. 2+/calmodulin-dependent protein kinase II stimulates c-fos transcription and DNA synthesis by a Src-based mechanism in glomerular mesangial cells. J Am Soc Nephrol 14: 28-36, 2003.
40. 2+/calmodulin-dependent protein kinases propogate signals from endothelin-1 receptors to the c-fos promoter. Mol Cell Biol 16: 5915-5923, 1996.
41. Wright TC Jr, Castellot JJ Jr, Diamond JR, and Karnovsky MJ. Regulation of cellular proliferation by heparin and heparan sulphate. In: Heparin: Chemical and Biological Properties, Clinical Applications, edited by Lane DA and Lindahls U. Boca Raton, FL: CRC, 1989, p. 295-316.
42. 2+/calmodulin-dependent and cAMP-dependent kinases in induction of c-fos in human mesangial cells. Am J Physiol Renal Physiol 283: F888-F894, 2002.
43. Zhao Y, Xiao W, and Templeton DM. Suppression of mitogen-activated protein kinase phosphatase-1 (MKP-1) by heparin in vascular smooth muscle cells. Biochem Pharmacol 66: 769-776, 2003.